Article

Genetic program activity delineates risk, relapse, and therapy responsiveness in Multiple Myeloma

2020-04-01

Abstract excerpt

Despite recent advancements in the treatment of multiple myeloma (MM), nearly all patients ultimately relapse and many become refractory to their previous therapies. Although many therapies exist with diverse mechanisms of action, it is not yet clear how the differences in MM biology across patients impacts the likelihood of success for existing therapies and those in the pipeline. Therefore, we not only need the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b77371a2-00c1-52fc-aa5a-de3a52fa4040
DOI: 10.1101/2020.04.01.012351

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic program activity delineates risk, relapse, and therapy responsiveness in Multiple MyelomaDOI 10.1101/2020.04.01.012351Read

Individualized dynamic risk assessment for multiple myelomaSemantic proximity Read

Germline and somatic genetic effects on gene expression and outcome in patients with Multiple MyelomaSemantic proximity Read

Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathwaysSemantic proximity Read

DNA damage repair (DDR) related prognostic risk model in multiple myeloma based on single-cell and bulk sequencing.Semantic proximity Read

Multi-omics analysis of multiple myeloma patients with differential response to first-line treatment.Semantic proximity Read

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.Semantic proximity Read

Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical OutcomesSemantic proximity Read

Dynamic super-enhancer core regulatory circuits and epigenetic landscapes drive malignant progression and refractory disease in multiple myelomaSemantic proximity Read

Integrative multi-omics identifies high risk Multiple Myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathwaysSemantic proximity Read

Genomic landscape of multiple myeloma and its precursor conditionsSemantic proximity Read

Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass StudySemantic proximity Read

Patient Similarity Network of Newly Diagnosed Multiple Myeloma Identifies Patient Sub-groups with Distinct Genetic Features and Clinical ImplicationsSemantic proximity Read